Organogenesis makes strides in Asia
This article was originally published in Clinica
In a move to extend its global reach, regenerative medicine specialist Organogenesis has forged a partnership with China's National Tissue Engineering Center (NTEC), a stem cell and regenerative medicine consortium comprising over 70 scientists and teams of regulatory, production and commercial professionals.
You may also be interested in...
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.
US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.